ROLE OF MILK IN COGNITIVE FUNCTION AND QUALITY OF LIFE IN OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT A1 protein free milk may provide enhanced outcomes
With
Dr Emma Beckett,
Food & Nutrition Scientist, FOODiQ Global
Professor Stephen Robinson, Psychology Research
Researcher and corresponding author &
semi-retired neuroscientist, RMIT University
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Melbourne and Newcastle, NSW | September 2025
New research emphasises the role of cows’ milk, particularly A1 protein free milk, in enhancing cognitive function and quality of life for older adults with mild cognitive impairment (MCI). A multi-centre, double-blinded, randomised controlled clinical study published in *The Journal of Nutrition, Health and Aging* evaluated 88 milk-tolerant Chinese adults aged 65-75 over three months. Participants consumed either ordinary skim milk or A1 protein free skim milk, leading to improvements in various cognitive assessments.
Both types of milk showed significant enhancements in cognitive performance across multiple tests, including the Subtle Cognitive Impairment Test (SCIT), Montreal Cognitive Assessment (MoCA), and Audio Verbal Learning Test (AVLT).
While both groups reported improvements in quality of life, the A1 protein free group noted greater gains, including a 23% increase in overall quality of life scores and a 43% improvement in memory ability. Despite challenges with vitamin D levels among participants, the study highlights the importance of milk choice in promoting cognitive health, especially for the aging population, where approximately 20% of those over 65 may experience MCI.
Researcher and corresponding author of the clinical study, Professor Stephen Robinson spoke to Australian Health Journal about the findings and the need for further research to confirm these benefits across diverse populations.
Dr Emma Beckett, food and nutrition scientist at FOODiQ, says A1PF milk, as part of a balanced diet, can play a valuable role in improving the nutrition of older adults.
“This is an exciting study because it shows that a small dietary change, adding A1PF milk, may be effective for those experiencing cognitive changes. As Australia’s population continues to age, A1PF milk may offer an accessible way to support overall health and wellbeing, particularly in adults living with MCI,” said Dr Beckett.
Source: Adapted from a2 Milk Australia media release and published study
You Might also like
-
Sharing the same goals in value-based procurement
Value-based procurement (VBP) is a journey, not a sprint. It’s about putting the patient at the centre of quality affordable healthcare through changes in procurement practices for medical technologies. Patient outcomes drive value and sustainability, not just price. The bigger picture indicates that VBP will create system cost saving through benefitting patients, rather than trying to attain the reverse – a win-win outcome.
-
Confronting picture of growing women’s health crisis in uterine cancers
Uterine cancers have become Australia’s fastest-growing women’s cancer, with incidence doubling over the past 25 years and projected to continue to surge. Without immediate action, more than 44,000 women are expected to be diagnosed by 2035, and 8,900 will lose their lives to the disease.
Released November 2025, Australia’s first State of the Nation: Uterine Cancers in Australia 2025 report by the Australia New Zealand Gynaecological Oncology Group (ANZGOG), reveals a confronting picture of a growing women’s health crisis that has gone largely unseen and one that now requires immediate, coordinated national action.
-
Role of the Chief Nursing Officer
Professor Alison McMillan PSM spoke with Australian Health Journal about the role of Chief Nursing and Midwifery Officer at the Australian Government Department of Health and Aged Care.
Alison was appointed as our Chief Nursing and Midwifery Officer in November 2019.
In June 2021 Alison was awarded a Public Service Medal for outstanding public service to driving the Government’s national health response priorities during the COVID-19 pandemic, particularly to infection prevention measures.